3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
235
Lung Neoplasms
106
Ovarian Neoplasms
81
Breast Neoplasms
81
Fallopian Tube Neoplasms
51
Small Cell Lung Carcinoma
42
Neoplasms
41
Triple Negative Breast Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
31
Head and Neck Neoplasms
25
Adenocarcinoma of Lung
25
Parkinson Disease 4, Autosomal Dominant Lewy Body
24
Carcinoma
23
Neoplasm Metastasis
20
Carcinoma, Ovarian Epithelial
18
Melanoma
14
Lymphoma, Large B-Cell, Diffuse
14
Carcinoma, Squamous Cell
14
Brain Neoplasms
14
Prostatic Neoplasms
13
Recurrence
12
Lymphoma
12
Endometrial Neoplasms
12
Adenocarcinoma, Bronchiolo-Alveolar
12
Esophageal Neoplasms
11
Lymphoma, Non-Hodgkin
10
Hodgkin Disease
10
Brenner Tumor
10
Urinary Bladder Neoplasms
9
Central Nervous System Neoplasms
9
Interventions
Rituximab
4
blinatumomab
3
Whole-Body Irradiation
3
Cyclophosphamide
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Clofarabine
2
treosulfan
1
thymoglobulin
1
sabatolimab
1
pembrolizumab
1
peginterferon alfa-2a
1
obinutuzumab
1
midostaurin
1
ixazomib
1
fludarabine
1
eribulin
1
daratumumab
1
acalabrutinib
1
Trastuzumab
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pentostatin
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm, Residual
×
Carboplatin
×
Clear all
No trials found.